product summary
company name :
Developmental Studies Hybridoma Bank
product type :
antibody
product name :
NEDD8-conjugating enzyme Ubc12
catalog :
AFFN-UBE2M-1A2
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
AFFN-UBE2M-1A2
reactivity :
human
application :
ELISA
more info or order :
citations: 2
Reference |
---|
Benjamin M, Toumi H, Suzuki D, Redman S, Emery P, McGonagle D. Microdamage and altered vascularity at the enthesis-bone interface provides an anatomic explanation for bone involvement in the HLA-B27-associated spondylarthritides and allied disorders. Arthritis Rheum. 2007;56:224-33 pubmed
|
product information
Internal ID :
19679
Name :
AFFN-UBE2M-1A2
Depositor Name :
EU Program Affinomics
Depositor Institution :
EMBL MACF
Depositor Website :
http://www.proteinbinders.org
Date Deposited :
12/3/14
Allow Hybridoma Distribution :
No
Cells Available (legacy) :
No
Antigen :
NEDD8-conjugating enzyme Ubc12
Antigen Species :
Human
Host Species :
mouse
Isotype :
MIgG
Positive Tested Species Reactivity :
Human
Initial Publication Pubmed ID :
21572409 17195019
Depositor Notes (Special Instructions) :
This antigen is also known as ubiquitin-conjugating enzyme E2M.
Collections :
EMBL-Affinomics,Human
Search Keywords :
EU Program Affinomics, NEDD8-conjugating enzyme Ubc12, Human, MIgG, Human, UBE2M, hUbc12, UBC12, , Monoclonal, EMBL-Affinomics/Human, ELISA/Microarray
Antigen Molecular Weight :
20.9 kDa
Gene :
UBE2M
Alternate Gene Name(s) :
hUbc12, UBC12
Uniprot ID :
P61081
Antibody Registry ID :
AB_2618000
Immunogen :
E. coli expressed recombinant protein
Clonality :
Monoclonal
Myeloma Strain :
SP2/0-AG14
Epitope Mapped :
No
Recommended Applications :
ELISA,Microarray
Depositor Growth Medium :
High glucose DMEM +20% FBS + 1% glutamine plus pen-strep
Additional Information :
This hybridoma was deposited as UBC12-1A2 RRID:AB_2618000
DSHB Growth Medium :
Iscove's
more info or order :
company information
Developmental Studies Hybridoma Bank
review
product type
related products
browse more products
questions and comments